Study of Chinese Newly Diagnosed Participants With Philadelphia Chromosome-Positive (Ph+) Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

Bristol-Myers Squibb (BMS)

Status: Completed

Conditions: Philadelphia Chromosome; Chronic Myeloid Leukemia; Chronic Myeloid Leukemia in Chronic Phase

Treatments: Other: Non-Interventional

Study type: Observational

Funder types: Industry

Identifiers

NCT03509896

CA180-681

Details and patient eligibility

About

Observational medical record review of newly diagnosed CML-CP participants in China

Enrollment: 463 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Ph+ CML-CP patients who were diagnosed between August 1, 2014 to August 1, 2016
• 18 years or older at time of diagnosis

Exclusion criteria

• Participants once enrolled in any interventional clinical trial for CML
• Participants whose records are not available

Other protocol defined inclusion/exclusion criteria could apply

Trial design

463 participants in 1 patient group

Participants newly diagnosed with CML-CP

Treatment:

Other: Non-Interventional